Standard BioTools Retained Earnings (Accumulated Deficit) 2010-2024 | LAB
Standard BioTools retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Standard BioTools Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-1,001 |
| 2022 | $-926 |
| 2021 | $-736 |
| 2020 | $-677 |
| 2019 | $-624 |
| 2018 | $-559 |
| 2017 | $-500 |
| 2016 | $-439 |
| 2015 | $-363 |
| 2014 | $-310 |
| 2013 | $-257 |
| 2012 | $-241 |
| 2011 | $-222 |
| 2010 | $-199 |
| 2009 | $-182 |
| Standard BioTools Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-1,125 |
| 2024-03-31 | $-1,079 |
| 2023-12-31 | $-1,001 |
| 2023-09-30 | $-981 |
| 2023-06-30 | $-960 |
| 2023-03-31 | $-943 |
| 2022-12-31 | $-926 |
| 2022-09-30 | $-905 |
| 2022-06-30 | $-876 |
| 2022-03-31 | $-812 |
| 2021-12-31 | $-736 |
| 2021-09-30 | $-727 |
| 2021-06-30 | $-713 |
| 2021-03-31 | $-696 |
| 2020-12-31 | $-677 |
| 2020-09-30 | $-659 |
| 2020-06-30 | $-653 |
| 2020-03-31 | $-640 |
| 2019-12-31 | $-624 |
| 2019-09-30 | $-611 |
| 2019-06-30 | $-598 |
| 2019-03-31 | $-584 |
| 2018-12-31 | $-559 |
| 2018-09-30 | $-544 |
| 2018-06-30 | $-529 |
| 2018-03-31 | $-513 |
| 2017-12-31 | $-500 |
| 2017-09-30 | $-490 |
| 2017-06-30 | $-474 |
| 2017-03-31 | $-457 |
| 2016-12-31 | $-439 |
| 2016-09-30 | $-422 |
| 2016-06-30 | $-402 |
| 2016-03-31 | $-383 |
| 2015-12-31 | $-363 |
| 2015-09-30 | $-351 |
| 2015-06-30 | $-341 |
| 2015-03-31 | $-326 |
| 2014-12-31 | $-310 |
| 2014-09-30 | $-299 |
| 2014-06-30 | $-285 |
| 2014-03-31 | $-273 |
| 2013-12-31 | $-257 |
| 2013-09-30 | $-253 |
| 2013-06-30 | $-248 |
| 2013-03-31 | $-244 |
| 2012-12-31 | $-241 |
| 2012-09-30 | $-237 |
| 2012-06-30 | $-233 |
| 2012-03-31 | $-228 |
| 2011-12-31 | $-222 |
| 2011-09-30 | $-218 |
| 2011-06-30 | $-214 |
| 2011-03-31 | $-207 |
| 2010-12-31 | $-199 |
| 2010-09-30 | $-196 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.753B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $40.428B | 21.75 |
| Tempus AI (TEM) | United States | $7.918B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.215B | 1157.72 |
| Axonics (AXNX) | United States | $3.513B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.503B | 203.88 |
| 10x Genomics (TXG) | United States | $2.660B | 0.00 |
| Enovis (ENOV) | United States | $2.437B | 17.67 |
| Azenta (AZTA) | United States | $2.413B | 137.03 |
| Privia Health (PRVA) | United States | $2.280B | 158.92 |
| IRhythm Technologies (IRTC) | United States | $2.219B | 0.00 |
| Omnicell (OMCL) | United States | $1.968B | 64.82 |
| Clover Health Investments (CLOV) | United States | $1.492B | 0.00 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Phreesia (PHR) | United States | $1.389B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.694B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.538B | 456.00 |
| Health Catalyst (HCAT) | United States | $0.529B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.406B | 0.00 |
| Talkspace (TALK) | United States | $0.343B | 0.00 |
| Pulmonx (LUNG) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.286B | 0.00 |
| TruBridge (TBRG) | United States | $0.183B | 13.44 |
| P3 Health Partners (PIII) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| 111 (YI) | China | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.036B | 0.00 |
| Outset Medical (OM) | United States | $0.034B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.025B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |